{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T01:22:34Z","timestamp":1771464154513,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,24]],"date-time":"2018-07-24T00:00:00Z","timestamp":1532390400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13000-018-0724-x","type":"journal-article","created":{"date-parts":[[2018,7,24]],"date-time":"2018-07-24T21:50:24Z","timestamp":1532469024000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Pure intravascular recurrence of CD5-positive diffuse large B-cell lymphoma primarily arising from the nasal cavities"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0735-1324","authenticated-orcid":false,"given":"Rieko","family":"Kano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Masaie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihisa","family":"Hino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironao","family":"Yasuoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigenori","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin-ichi","family":"Nakatsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,24]]},"reference":[{"key":"724_CR1","first-page":"207","volume":"147","author":"A Matolcsy","year":"1995","unstructured":"Matolcsy A, Chadburn A, Knowles DM. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct. Am J Pathol. 1995;147:207\u201316.","journal-title":"Am J Pathol"},{"key":"724_CR2","doi-asserted-by":"publisher","first-page":"5615","DOI":"10.18632\/oncotarget.3479","volume":"6","author":"ZY Xu-Monette","year":"2015","unstructured":"Xu-Monette ZY, Tu M, Jabbar KJ, Cao X, Tzankov A, Visco C, et al. Clinical and biological significance of de novo CD5+ diffuse large B-cell lymphoma in western countries. Oncotarget. 2015;6:5615\u201333.","journal-title":"Oncotarget"},{"key":"724_CR3","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1093\/annonc\/mdq627","volume":"22","author":"K Miyazaki","year":"2011","unstructured":"Miyazaki K, Yamaguchi M, Suzuki R, Kobayashi Y, Maeshima AM, Niitsu N, et al. CD5-positive diffuse large B-cell lymphoma: a retrospective study in 337 patients treated by chemotherapy with or without rituximab. Ann Oncol. 2011;22:1601\u20137.","journal-title":"Ann Oncol"},{"key":"724_CR4","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.3324\/haematol.12810","volume":"93","author":"M Yamaguchi","year":"2008","unstructured":"Yamaguchi M, Nakamura N, Suzuki R, Kagami Y, Okamoto M, Ichinohasama R, et al. De novo CD5+ diffuse large B-cell lymphoma: results of a detailed clinicopathological review in 120 patients. Haematologica. 2008;93:1195\u2013202.","journal-title":"Haematologica"},{"key":"724_CR5","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1182\/blood.V99.3.815","volume":"99","author":"M Yamaguchi","year":"2002","unstructured":"Yamaguchi M, Seto M, Okamoto M, Ichinohasama R, Nakamura N, Yoshino T, et al. De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients. Blood. 2002;99:815\u201321.","journal-title":"Blood"},{"key":"724_CR6","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1182\/blood-2005-02-0542","volume":"106","author":"H Tagawa","year":"2005","unstructured":"Tagawa H, Suguro M, Tsuzuki S, Matsuo K, Karnan S, Ohshima K, et al. Comparison of genome profiles for identification of distinct subgroups of diffuse large B-celllymphoma. Blood. 2005;106:1770\u20137.","journal-title":"Blood"},{"key":"724_CR7","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1093\/annonc\/mdq057","volume":"21","author":"N Niitsu","year":"2010","unstructured":"Niitsu N, Okamoto M, Tamaru JI, Yoshino T, Nakamura N, Nakamura S, et al. Clinicopathologic characteristics and treatment outcome of the addition of rituximab to chemotherapy for CD5-positive in comparison with CD5-negative diffuse large B-cell lymphoma. Ann Oncol. 2010;21:2069\u201374.","journal-title":"Ann Oncol"},{"key":"724_CR8","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1182\/blood-2006-01-021253","volume":"109","author":"T Murase","year":"2007","unstructured":"Murase T, Yamaguchi M, Suzuki R, Okamoto M, Sato Y, Tamaru J, et al. Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic hererogeneity of CD5. Blood. 2007;109:478\u201385.","journal-title":"Blood"},{"key":"724_CR9","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1182\/blood.V104.11.1365.1365","volume":"104","author":"T Murase","year":"2004","unstructured":"Murase T, Suzuki R, Yamaguchi M, Okamoto M, Sato Y, Tamaru J, et al. High incidence of Asian variant intravascular large B-cell lymphoma (IVL) among IVL in Japan: Clinicopathologic study of 95 patients. Blood. 2004;104:1365.","journal-title":"Blood"},{"key":"724_CR10","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/modpathol.3880450","volume":"14","author":"S Yegappan","year":"2001","unstructured":"Yegappan S, Coupland R, Arber DA, Wang N, Miocinovic R, Tubbs RR, et al. Angiotropic lymphoma: an immunophenotypically and clinically heterogeneous lymphoma. Mod Pathol. 2001;14:1147\u201356.","journal-title":"Mod Pathol"},{"key":"724_CR11","doi-asserted-by":"publisher","unstructured":"Filipovich AH. Hemophagocytic lymphohistiocytosis (HLH) and related disorders. Hematol Am Soc Hematol Educ Program. 2009:127\u201331. https:\/\/doi.org\/10.1182\/asheducation-2009.1.127 .","DOI":"10.1182\/asheducation-2009.1.127"},{"key":"724_CR12","volume-title":"WHO classification of Tumours of Haematopoietic and lymphoid tissues","author":"SH Swerdlow","year":"2017","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO classification of Tumours of Haematopoietic and lymphoid tissues. Revised 4th ed. Lyon: IARC; 2017.","edition":"Revised 4th"},{"key":"724_CR13","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1080\/10428194.2017.1287363","volume":"58","author":"DJ Rajyaguru","year":"2017","unstructured":"Rajyaguru DJ, Bhaskar C, Borgert AJ, Smith A, Parsons B. Intravascular large B-cell lymphoma in the United States (US): a population-based study using surveillance, epidemiology, and end results program and National Cancer Database. Leuk Lymphoma. 2017;58:2080\u20138.","journal-title":"Leuk Lymphoma."},{"key":"724_CR14","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/j.1365-2141.2004.05177.x","volume":"127","author":"AJ Ferreri","year":"2004","unstructured":"Ferreri AJ, Campo E, Seymour JF, Willemze R, Ilariucci F, Ambrosetti A, et al. Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the 'cutaneous variant. Br J Haematol. 2004;127:173\u201383.","journal-title":"Br J Haematol"},{"key":"724_CR15","doi-asserted-by":"publisher","first-page":"486","DOI":"10.3324\/haematol.10829","volume":"92","author":"AJ Ferreri","year":"2007","unstructured":"Ferreri AJ, Dognini GP, Campo E, Willemze R, Seymour JF, Bairey O, et al. Variations in clinical presentation, frequency of hemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regions. Haematologica. 2007;92:486\u201392.","journal-title":"Haematologica"},{"key":"724_CR16","doi-asserted-by":"publisher","first-page":"3168","DOI":"10.1200\/JCO.2006.08.2313","volume":"25","author":"M Ponzoni","year":"2007","unstructured":"Ponzoni M, Ferreri AJ, Campo E, Facchetti F, Mazzucchelli L, Yoshino T, et al. Definition, diagnosis, and management of intravascular large B-cell lymphoma: proposals and perspectives from an international consensus meeting. J Clin Oncol. 2007;25:3168\u201373.","journal-title":"J Clin Oncol"},{"key":"724_CR17","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1746-1596-8-81","volume":"8","author":"T Igawa","year":"2013","unstructured":"Igawa T, Sato Y, Takata K, Iwaki N, Tanaka T, Asano N, et al. De novo CD5-positive diffuse large B-cell lymphomas show high specificity for cyclin D2 expression. Diagn Pathol. 2013;8:81.","journal-title":"Diagn Pathol"},{"key":"724_CR18","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1056\/NEJMoa032520","volume":"350","author":"IS Lossos","year":"2004","unstructured":"Lossos IS, Czerwinski DK, Alizadeh AA, Wechser MA, Tibshirani R, Botstein D, et al. Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. N Engl J Med. 2004;350:1828\u201337.","journal-title":"N Engl J Med"},{"key":"724_CR19","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1038\/modpathol.3800434","volume":"18","author":"CP Hans","year":"2005","unstructured":"Hans CP, Weisenburger DD, Greiner TC, Chan WC, Aoun P, Cochran GT, et al. Expression of PKC-beta or cyclin D2 predicts for inferior survival in diffuse large B-cell lymphoma. Mod Pathol. 2005;18:1377\u201384.","journal-title":"Mod Pathol"},{"key":"724_CR20","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.3109\/10428194.2013.786071","volume":"54","author":"PA McKelvie","year":"2013","unstructured":"McKelvie PA, Wools C, Roberts L, Cook M. Intravascular large B-cell lymphoma. occurring 25 years after treatment of ALK-positive anaplastic large cell lymphoma. Leuk Lymphoma. 2013;54:2745\u20137.","journal-title":"Leuk Lymphoma"},{"key":"724_CR21","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1002\/ccr3.1087","volume":"5","author":"R Puckrin","year":"2017","unstructured":"Puckrin R, Pop P, Ghorab Z, Keith J, Chodirker L, Lin Y, et al. Intravascular large B-cell lymphoma presenting as Richter's syndrome with cerebral involvement in a patient with chronic lymphocytic leukemia. Clin Case Rep. 2017;5:1444\u20139.","journal-title":"Clin Case Rep"},{"key":"724_CR22","first-page":"637","volume":"8","author":"DA Katz","year":"2010","unstructured":"Katz DA, Miller IJ, Gregory SA. Intravascular B-cell lymphoma following nodal diffuse large B-cell lymphoma. Clin Adv Hematol Oncol. 2010;8:637\u201341.","journal-title":"Clin Adv Hematol Oncol"},{"key":"724_CR23","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/j.1346-8138.2010.01127.x","volume":"38","author":"A Kasuya","year":"2011","unstructured":"Kasuya A, Hashizume H, Takigawa M. Early diagnosis of recurrent diffuse large. B-cell lymphoma showing intravascular lymphoma by random skin biopsy. J Dermatol. 2011;38:571\u20134.","journal-title":"J Dermatol"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-018-0724-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13000-018-0724-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-018-0724-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T16:17:05Z","timestamp":1604679425000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-018-0724-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,24]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["724"],"URL":"https:\/\/doi.org\/10.1186\/s13000-018-0724-x","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,24]]},"assertion":[{"value":"11 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The ethical approval and documentation for a case report was waived with the Institutional Review Board of Osaka International Cancer Institute Hospital.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the consent form is available for review by the Editor of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"46"}}